Researchers at the University of North Carolina at Chapel Hill have patented a synthetic version of the drug heparin, called Recomparin, that is less complex chemically and should be easier to produce than previous forms.
Pharmaceutical company GenVec’s malaria vaccine candidate is well-tolerated and induces an immune response, according to results from a Phase I/II clinical trial presented by the company at the Malaria Vaccines for the World Conference at the Royal Society of Medicine in London.
Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced publication of a study by Sirtris and Harvard University scientists in the journal Cell that reveals a new mechanism to slow aging.
Quong Hop & Co. of South San Francisco, California is recalling all SOY DELI brand tofu with code date DEC 17 2007 and certain varieties of SOY DELI and QUONG HOP brand tofu with code date SEP 23 2007.
Bravo! announces a voluntary recall of select tubes of three of its poultry products for cats and dogs. The pet food is being recalled because two of the products have the potential to be contaminated with Salmonella and Listeria monocytogenes, while the other product has the potential to be contaminated with Listeria monocytogenes.
Strong America Ltd. of Long Island City, NY is recalling Chinese Wolfberry, because it may contain undeclared sulfites. People who have a severe sensitivity to sulfites run the risk of serious or life-threatening reactions if they consume this product.
Eli Lilly and Company announced that it has submitted an application with the European Medicines Agency (EMEA) for centralised review of ALIMTA(R) (pemetrexed for injection), in combination with cisplatin, for the first-line treatment of advanced non-small cell lung cancer (NSCLC).
New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), further support the cardiovascular safety of ACTOS (pioglitazone HCI) and its benefits regarding improved blood glucose and blood lipid levels for patients with type 2 diabetes.
Cancer Research UK funded a record £315m of research last year. The milestone marks nearly a doubling in research funding since the Charity was formed five years ago, according to its annual report and accounts published today (Friday 14 September 2007).
Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) announced that its researchers have discovered a monoclonal antibody that is active against H5N1 avian influenza. The studies will be presented at the 5th International Bird Flu Summit scheduled for September 27 and 28 in Las Vegas, Nevada.